Keywords

long-chain noncoding RNA, breast cancer, diagnosis, treatment, expression

References

[1]       Lei Fan, Kathrin Strasser-Weippl, Jun-Jie Li, et al. (2014). Breast cancer in China [J]. The Lancet Oncology, 15(7): e279-e289.

[2]       W. Chen, R. Zheng, P. D. Baade, et al. (2016). Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 66(2): 115-32.

[3]       Timothy J. Key, Pia K. Verkasalo, Emily Banks. (2001). Epidemiology of breast cancer [J]. The Lancet Oncology, 2(3): 133-140.

[4]       Ben Zhang, Alicia Beeghly-Fadiel, Jirong Long, et al. (2011). Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence [J]. The Lancet Oncology, 12(5): 477-488.

[5]       Xu Yali, Sun Qiang, Shan Guangliang, et al. (2012). Risk Factors of Breast Cancer in China: A Case-Control Study [J]. Medical Journal of Peking Union Medical College Hospital, 01: 7-14.

[6]       J. S. Mattick, I. V. Makunin. (2006). Non-coding RNA [J]. Hum Mol Genet, 15 Spec No 1: R17-29.

[7]       A. Lujambio, S. W. Lowe. (2012). The microcosmos of cancer [J]. Nature, 482(7385): 347-55.

[8]       E. Berezikov. (2011). Evolution of microRNA diversity and regulation in animals [J]. Nat Rev Genet, 12(12): 846-60.

[9]       J. E. Wilusz, H. Sunwoo, D. L. Spector. (2009). Long noncoding RNAs: functional surprises from the RNA world [J]. Genes Dev, 23(13): 1494-504.

[10]    R. J. Taft, M. Pheasant, J. S. Mattick. (2007). The relationship between non-protein-coding DNA and eukaryotic complexity [J]. Bioessays, 29(3): 288-99.

[11]    J. Cao, C. Luo, R. Peng, et al. (2016). MiRNA-binding site functional polymorphisms in DNA repair genes RAD51, RAD52, and XRCC2 and breast cancer risk in Chinese population [J].Tumor Biol, 2016.

[12]    J. Cao, C. Luo, R. Yan, et al. (2016). rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility [J]. Med Oncol, 33(12): 135.

[13]    J. S. Mattick. (2009). The genetic signatures of noncoding RNAs [J]. PLoS Genet, 5(4): e1000459.

[14]    M. C. Lai, Z. Yang, L. Zhou, et al. (2012). Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation [J]. Med Oncol, 29(3): 1810-6.

[15]    C. Braconi, N. Valeri, T. Kogure, et al. (2011). Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma [J]. Proc Natl Acad Sci U S A, 108(2): 786-91.

[16]    H. Sun, G. Wang, Y. Peng, et al. (2015). H19 lncRNA mediates 17beta-estradiol-induced cell proliferation in MCF-7 breast cancer cells [J]. Oncol Rep, 33(6): 3045-52.

[17]    R. Vikram, R. Ramachandran, K. S. Abdul. (2014). Functional significance of long non-coding RNAs in breast cancer [J]. Breast Cancer, 21(5): 515-21.

[18]    Y. Li, X. Wang. (2016). Role of long noncoding RNAs in malignant disease (Review) [J]. Mol Med Rep, 13(2): 1463-9.

[19]    M. Guttman, I. Amit, M. Garber, et al. (2009). Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals [J]. Nature, 458(7235): 223-7.

[20]    T. Derrien, R. Johnson, G. Bussotti, et al. (2012). The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression [J]. Genome Res, 22(9): 1775-89.

[21]    S. J. Andrews, J. A. Rothnagel. (2014). Emerging evidence for functional peptides encoded by short open reading frames [J]. Nat Rev Genet, 15(3): 193-204.

[22]    A. I. Nesvizhskii. (2014). Proteogenomics: concepts, applications and computational strategies [J]. Nat Methods, 11(11): 1114-25.

[23]    P. J. Batista, H. Y. Chang. Long noncoding RNAs: cellular address codes in development and disease [J]. Cell, 2013, 152(6): 1298-307.

[24]    Xia Tian, Xiao Bingxiu, Guo Junming. (2013). Mechanism of Long-chain Noncoding RNA and Its Research Methods [J]. Heredity, 03: 269-280.

[25]    J. L. Rinn, M. Kertesz, J. K. Wang, et al. (2007). Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs [J]. Cell, 129(7): 1311-23.

[26]    R. A. Gupta, N. Shah, K. C. Wang, et al. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis [J]. Nature, 464(7291): 1071-6.

[27]    K. M. Chisholm, Y. Wan, R. Li, et al. (2012). Detection of long non-coding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma [J]. PLoS One, 7(10): e47998.

[28]    M. C. Tsai, O. Manor, Y. Wan, et al. (2010). Long noncoding RNA as modular scaffold of histone modification complexes [J]. Science, 329(5992): 689-93.

[29]    S. Bayram, A. T. Sumbul, C. Y. Batmaci, et al. (2015). Effect of HOTAIR rs920778 polymorphism on breast cancer susceptibility and clinicopathologic features in a Turkish population [J]. Tumour Biol, 36(5): 3863-70.

[30]    R. Yan, J. Cao, C. Song, et al. (2015). Polymorphisms in lncRNA HOTAIR and susceptibility to breast cancer in a Chinese population [J]. Cancer Epidemiol, 39(6): 978-85.

[31]    Y. Zhang, B. Tycko. (1992). Monoallelic expression of the human H19 gene [J]. Nat Genet, 1(1): 40-4.

[32]    K. Hibi, H. Nakamura, A. Hirai, et al. (1996). Loss of H19 imprinting in esophageal cancer [J]. Cancer Res, 56(3): 480-2.

[33]    Y. Fellig, I. Ariel, P. Ohana, et al. (2005). H19 expression in hepatic metastases from a range of human carcinomas [J]. J Clin Pathol, 58(10): 1064-8.

[34]    C. Vennin, N. Spruyt, F. Dahmani, et al. (2015). H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b [J]. Oncotarget, 6(30): 29209-23.

[35]    N. Berteaux, S. Lottin, D. Monte, et al. (2005). H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1 [J]. J Biol Chem, 280(33): 29625-36.

[36]    Jun Lv, Ya-Qun Yu, Shu-Qun Li, et al. (2014). Aflatoxin B1 Promotes Cell Growth and Invasion in Hepatocellular Carcinoma HepG2 Cells through H19 and E2F1 [J]. Asian Pacific Journal of Cancer Prevention, 15(6): 2565-2570.

[37]    W. P. Tsang, E. K. Ng, S. S. Ng, et al. (2010). Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer [J]. Carcinogenesis, 31(3): 350-8.

[38]    C. Ma, X. Shi, Q. Zhu, et al. (2016). The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers [J]. Tumour Biol, 37(2): 1437-44.

[39]    M. Mourtada-Maarabouni, M. R. Pickard, V. L. Hedge, et al. (2009). GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer [J]. Oncogene, 28(2): 195-208.

[40]    M. R. Pickard, G. T. Williams. (2014). Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy [J]. Breast Cancer Res Treat, 145(2): 359-70.

[41]    W. Li, L. Zhai, H. Wang, et al. (2016). Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer [J]. Oncotarget, 7(19): 27778-86.

[42]    Z. Zhang, Z. Zhu, K. Watabe, et al. (2013). Negative regulation of lncRNA GAS5 by miR-21 [J]. Cell Death Differ, 20(11): 1558-68.

[43]    A. Guffanti, M. Iacono, P. Pelucchi, et al. (2009). A transcriptional sketch of a primary human breast cancer by 454 deep sequencing [J]. BMC Genomics, 10: 163.

[44]    T. Gutschner, M. Hammerle, M. Eissmann, et al. (2013). The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells [J]. Cancer Res, 73(3): 1180-9.

[45]    J. M. Silva, D. S. Perez, J. R. Pritchett, et al. (2010). Identification of long stress-induced non-coding transcripts that have altered expression in cancer [J]. Genomics, 95(6): 355-62.

[46]    J. M. Silva, N. J. Boczek, M. W. Berres, et al. (2011). LSINCT5 is overexpressed in breast and ovarian cancer and affects cellular proliferation [J]. Rna Biology, 8(3): 496-505.

[47]    C. M. Klinge, S. C. Jernigan, K. A. Mattingly, et al. (2004). Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivatorsand corepressors [J]. J Mol Endocrinol, 33(2): 387-410.

[48]    R. B. Lanz, S. S. Chua, N. Barron, et al. (2003). Steroid Receptor RNA Activator Stimulates Proliferation as Well as Apoptosis In Vivo [J]. Molecular and Cellular Biology, 23(20): 7163-7176.

[49]    H. Yao, K. Brick, Y. Evrard, et al. (2010). Mediation of CTCF transcriptional insulation by DEAD-box RNA-binding protein p68 and steroid receptor RNA activator SRA [J]. Genes Dev, 24(22): 2543-55.

[50]    Xiansi Zhao, Jeffrey R. Patton, Sajal K. Ghosh, et al. (2007). Pus3p-and pus1p-dependentpseudouridylation of steroid receptor RNA activator controls a functional switch thatregulates nuclear receptor signaling [J]. Molecular Endocrinology, 21(3): 686-699.

[51]    R. Yan, K. Wang, R. Peng, et al. (2016). Genetic variants in lncRNA SRA and risk of breast cancer [J]. Oncotarget, 7: 22486-22496.

[52]    E. Emberley, G. J. Huang, M. K. Hamedani, et al. (2003). Identification of new human coding steroid receptor RNA activator isoforms [J]. Biochem Biophys Res Commun, 301(2): 509-15.